Analyst ratings and price targets
Company news as it is published. Each story lists the tickers it names with today's move, and opens in full here.
Analyst ratings Benzinga
Freedom Capital Markets Maintains Hold on LivaNova, Raises Price Target to $89Freedom Capital Markets analyst Keith Hinton maintains LivaNova (NASDAQ:LIVN) with a Hold and raises the price target from $75 to $89.
Analyst ratings Benzinga
Rosenblatt Maintains Buy on Webull, Lowers Price Target to $10Rosenblatt analyst Chris Brendler maintains Webull (NASDAQ:BULL) with a Buy and lowers the price target from $12 to $10.
Analyst ratings Benzinga
Telsey Advisory Group Maintains Outperform on Williams-Sonoma, Lowers Price Target to $280Telsey Advisory Group analyst Cristina Fernandez maintains Williams-Sonoma (NYSE:WSM) with a Outperform and lowers the price target from $285 to $280.
Analyst ratings Benzinga
Telsey Advisory Group Maintains Outperform on Walmart, Raises Price Target to $145Telsey Advisory Group analyst Joseph Feldman maintains Walmart (NASDAQ:WMT) with a Outperform and raises the price target from $130 to $145.
Analyst ratings Benzinga
Telsey Advisory Group Maintains Outperform on Gap, Lowers Price Target to $26Telsey Advisory Group analyst Dana Telsey maintains Gap (NYSE:GAP) with a Outperform and lowers the price target from $34 to $26.
Analyst ratings Benzinga
Citigroup Maintains Neutral on APA, Raises Price Target to $48Citigroup analyst Scott Gruber maintains APA (NASDAQ:APA) with a Neutral and raises the price target from $44 to $48.
Analyst ratings Benzinga
Citigroup Maintains Neutral on Sunstone Hotel Invts, Raises Price Target to $13Citigroup analyst Nick Joseph maintains Sunstone Hotel Invts (NYSE:SHO) with a Neutral and raises the price target from $10 to $13.
Analyst ratings Benzinga
Citigroup Maintains Buy on Keysight Techs, Lowers Price Target to $345Citigroup analyst Atif Malik maintains Keysight Techs (NYSE:KEYS) with a Buy and lowers the price target from $400 to $345.
Analyst ratings Benzinga
Citigroup Maintains Neutral on Williams-Sonoma, Lowers Price Target to $245Citigroup analyst Steven Zaccone maintains Williams-Sonoma (NYSE:WSM) with a Neutral and lowers the price target from $275 to $245.
Analyst ratings Benzinga
Citigroup Maintains Buy on Procter & Gamble, Raises Price Target to $190Citigroup analyst Filippo Falorni maintains Procter & Gamble (NYSE:PG) with a Buy and raises the price target from $187 to $190.
Analyst ratings Benzinga
Citigroup Maintains Buy on Nextpower, Lowers Price Target to $124Citigroup analyst Vikram Bagri maintains Nextpower (NASDAQ:NXT) with a Buy and lowers the price target from $126 to $124.
Analyst ratings Benzinga
Citigroup Maintains Buy on Alibaba Gr Hldgs, Lowers Price Target to $160Citigroup analyst Alicia Yap maintains Alibaba Gr Hldgs (NYSE:BABA) with a Buy and lowers the price target from $193 to $160.
Analyst ratings Benzinga
Macquarie Downgrades Grandstand to Neutral, Announces $1 Price TargetMacquarie analyst Chad Beynon downgrades Grandstand (NASDAQ:GRSD) from Outperform to Neutral and announces $1 price target.
Analyst ratings Benzinga
Lake Street Maintains Buy on Insight Molecular, Lowers Price Target to $9Lake Street analyst Thomas Flaten maintains Insight Molecular (NASDAQ:IMDX) with a Buy and lowers the price target from $12 to $9.
Analyst ratings Benzinga
KGI Securities Downgrades Lowe's Companies to Neutral, Announces $231 Price TargetKGI Securities analyst Tommy Lai downgrades Lowe's Companies (NYSE:LOW) from Outperform to Neutral and announces $231 price target.
Analyst ratings Benzinga
Johnson Rice Upgrades Crescent Energy to Buy, Announces $20 Price TargetJohnson Rice analyst Charles Meade upgrades Crescent Energy (NYSE:CRGY) from Accumulate to Buy and announces $20 price target.
Analyst ratings Benzinga
Johnson Rice Upgrades Viper Energy to Buy, Announces $58 Price TargetJohnson Rice analyst Charles Meade upgrades Viper Energy (NASDAQ:VNOM) from Accumulate to Buy and announces $58 price target.
Analyst ratings Benzinga
Johnson Rice Downgrades Mach Natural Resources to Accumulate, Announces $13 Price TargetJohnson Rice analyst Charles Meade downgrades Mach Natural Resources (NYSE:MNR) from Buy to Accumulate and announces $13 price target.
Analyst ratings Benzinga
Jefferies Maintains Buy on Warner Music Gr, Raises Price Target to $38Jefferies analyst Andrew Uerkwitz maintains Warner Music Gr (NASDAQ:WMG) with a Buy and raises the price target from $32 to $38.
Analyst ratings Benzinga
Jefferies Maintains Buy on Walmart, Raises Price Target to $145Jefferies analyst Corey Tarlowe maintains Walmart (NASDAQ:WMT) with a Buy and raises the price target from $120 to $145.
Analyst ratings Benzinga
Jefferies Maintains Buy on Intuit, Lowers Price Target to $445Jefferies analyst Brent Thill maintains Intuit (NASDAQ:INTU) with a Buy and lowers the price target from $500 to $445.
Analyst ratings Benzinga
Jefferies Maintains Buy on Elastic, Lowers Price Target to $100Jefferies analyst Brent Thill maintains Elastic (NYSE:ESTC) with a Buy and lowers the price target from $110 to $100.
Analyst ratings Benzinga
UBS Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $31UBS analyst David Dai maintains Syndax Pharmaceuticals (NASDAQ:SNDX) with a Buy and lowers the price target from $33 to $31.
Analyst ratings Benzinga
UBS Maintains Buy on Ross Stores, Lowers Price Target to $307UBS analyst Jay Sole maintains Ross Stores (NASDAQ:ROST) with a Buy and lowers the price target from $315 to $307.
Analyst ratings Benzinga
UBS Maintains Buy on Nu Holdings, Lowers Price Target to $17.8UBS analyst Thiago Batista maintains Nu Holdings (NYSE:NU) with a Buy and lowers the price target from $20.5 to $17.8.
Analyst ratings Benzinga
UBS Maintains Neutral on Norwegian Cruise Line, Lowers Price Target to $19UBS analyst Robin Farley maintains Norwegian Cruise Line (NYSE:NCLH) with a Neutral and lowers the price target from $20 to $19.
Analyst ratings Benzinga
UBS Maintains Buy on Meritage Homes, Lowers Price Target to $80UBS analyst John Lovallo maintains Meritage Homes (NYSE:MTH) with a Buy and lowers the price target from $85 to $80.
Analyst ratings Benzinga
UBS Maintains Buy on Keysight Techs, Lowers Price Target to $380UBS analyst Andrew Spinola maintains Keysight Techs (NYSE:KEYS) with a Buy and lowers the price target from $440 to $380.
Analyst ratings Benzinga
UBS Maintains Neutral on Intuit, Lowers Price Target to $315UBS analyst Taylor McGinnis maintains Intuit (NASDAQ:INTU) with a Neutral and lowers the price target from $360 to $315.
Earnings Benzinga
Walmart Gets Bullish Rating Despite Pharmacy Deflation HeadwindsBTIG expects Walmart's underlying demand to remain healthy while Maximum Fair Price pharmacy deflation continues weighing on reported comparable sales.

Analyst ratings Benzinga
UBS Maintains Neutral on Ingredion, Lowers Price Target to $98UBS analyst Joshua Spector maintains Ingredion (NYSE:INGR) with a Neutral and lowers the price target from $104 to $98.
Analyst ratings Benzinga
UBS Maintains Neutral on Hewlett Packard, Lowers Price Target to $52UBS analyst David Vogt maintains Hewlett Packard (NYSE:HPE) with a Neutral and lowers the price target from $66 to $52.
Analyst ratings Benzinga
UBS Maintains Neutral on Bath & Body Works, Lowers Price Target to $19UBS analyst Jay Sole maintains Bath & Body Works (NYSE:BBWI) with a Neutral and lowers the price target from $22 to $19.
Analyst ratings Benzinga
UBS Maintains Neutral on Williams-Sonoma, Lowers Price Target to $250UBS analyst Michael Lasser maintains Williams-Sonoma (NYSE:WSM) with a Neutral and lowers the price target from $265 to $250.
Analyst ratings Benzinga
JP Morgan Maintains Neutral on Williams-Sonoma, Lowers Price Target to $245JP Morgan analyst Christopher Horvers maintains Williams-Sonoma (NYSE:WSM) with a Neutral and lowers the price target from $255 to $245.
Analyst ratings Benzinga
JP Morgan Maintains Overweight on MSG Knickerbockers, Lowers Price Target to $385JP Morgan analyst David Karnovsky maintains MSG Knickerbockers (NYSE:MSGK) with a Overweight and lowers the price target from $485 to $385.
Analyst ratings Benzinga
JP Morgan Maintains Neutral on Intuit, Lowers Price Target to $321JP Morgan analyst Samik Chatterjee maintains Intuit (NASDAQ:INTU) with a Neutral and lowers the price target from $331 to $321.
Analyst ratings Benzinga
JP Morgan Maintains Overweight on IDEAYA Biosciences, Lowers Price Target to $55JP Morgan analyst Anupam Rama maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Overweight and lowers the price target from $62 to $55.
Analyst ratings Benzinga
HC Wainwright & Co. Maintains Buy on Savara, Lowers Price Target to $9HC Wainwright & Co. analyst Matthew Caufield maintains Savara (NASDAQ:SVRA) with a Buy and lowers the price target from $10 to $9.
Analyst ratings Benzinga
Raymond James Maintains Strong Buy on Diamondback Energy, Lowers Price Target to $246Raymond James analyst John Freeman maintains Diamondback Energy (NASDAQ:FANG) with a Strong Buy and lowers the price target from $256 to $246.
Analyst ratings Benzinga
Raymond James Maintains Outperform on Walmart, Raises Price Target to $140Raymond James analyst Bobby Griffin maintains Walmart (NASDAQ:WMT) with a Outperform and raises the price target from $130 to $140.
Analyst ratings Benzinga
JP Morgan Maintains Overweight on Enanta Pharmaceuticals, Lowers Price Target to $17JP Morgan analyst Anupam Rama maintains Enanta Pharmaceuticals (NASDAQ:ENTA) with a Overweight and lowers the price target from $19 to $17.
Analyst ratings Benzinga
Craig-Hallum Maintains Buy on Grandstand, Lowers Price Target to $3Craig-Hallum analyst Ryan Sigdahl maintains Grandstand (NASDAQ:GRSD) with a Buy and lowers the price target from $6 to $3.
Analyst ratings Benzinga
Craig-Hallum Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $16Craig-Hallum analyst Adam Vogel initiates coverage on Quoin Pharmaceuticals (NASDAQ:QNRX) with a Buy rating and announces Price Target of $16.
Analyst ratings Benzinga
JP Morgan Maintains Overweight on Cytokinetics, Lowers Price Target to $100JP Morgan analyst Tessa Romero maintains Cytokinetics (NASDAQ:CYTK) with a Overweight and lowers the price target from $103 to $100.
Analyst ratings Benzinga
JP Morgan Maintains Neutral on Bath & Body Works, Lowers Price Target to $23JP Morgan analyst Matthew Boss maintains Bath & Body Works (NYSE:BBWI) with a Neutral and lowers the price target from $24 to $23.
Analyst ratings Benzinga
B of A Securities Maintains Buy on Bath & Body Works, Lowers Price Target to $25B of A Securities analyst Lorraine Hutchinson maintains Bath & Body Works (NYSE:BBWI) with a Buy and lowers the price target from $30 to $25.
Analyst ratings Benzinga
JP Morgan Maintains Neutral on Agios Pharmaceuticals, Lowers Price Target to $30JP Morgan analyst Tessa Romero maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Neutral and lowers the price target from $34 to $30.
Analyst ratings Benzinga
HC Wainwright & Co. Maintains Buy on Alpha Tau Medical, Raises Price Target to $18HC Wainwright & Co. analyst Yi Chen maintains Alpha Tau Medical (NASDAQ:DRTS) with a Buy and raises the price target from $16 to $18.
Analyst ratings Benzinga
B of A Securities Maintains Neutral on Warner Music Gr, Raises Price Target to $35B of A Securities analyst Jessica Reif Cohen maintains Warner Music Gr (NASDAQ:WMG) with a Neutral and raises the price target from $30 to $35.
